125 related articles for article (PubMed ID: 18956769)
1. [Action and resistance mechanisms of capreomycin: a functional genomic perspective].
Liu XM; Xie JP
Yao Xue Xue Bao; 2008 Aug; 43(8):788-92. PubMed ID: 18956769
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide exploration of the drug action of capreomycin on Mycobacterium tuberculosis using Affymetrix oligonucleotide GeneChips.
Fu LM; Shinnick TM
J Infect; 2007 Mar; 54(3):277-84. PubMed ID: 16822547
[TBL] [Abstract][Full Text] [Related]
3. The copper (II) ion as a carrier for the antibiotic capreomycin against Mycobacterium tuberculosis.
Manning T; Mikula R; Lee H; Calvin A; Darrah J; Wylie G; Phillips D; Bythell BJ
Bioorg Med Chem Lett; 2014 Feb; 24(3):976-82. PubMed ID: 24424129
[TBL] [Abstract][Full Text] [Related]
4. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.
Maus CE; Plikaytis BB; Shinnick TM
Antimicrob Agents Chemother; 2005 Feb; 49(2):571-7. PubMed ID: 15673735
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.
Maus CE; Plikaytis BB; Shinnick TM
Antimicrob Agents Chemother; 2005 Aug; 49(8):3192-7. PubMed ID: 16048924
[TBL] [Abstract][Full Text] [Related]
6. The interaction topology of Mycobacterium tuberculosis genes response to capreomycin and novel clues for more drug targets.
Zheng F; Xie J
J Cell Biochem; 2011 Oct; 112(10):2716-20. PubMed ID: 21678479
[TBL] [Abstract][Full Text] [Related]
7. Predicting the future trend of drug-resistant tuberculosis in Thailand: assessing the impact of control strategies.
Nishiura H; Patanarapelert K; Tang IM
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):649-56. PubMed ID: 15689082
[TBL] [Abstract][Full Text] [Related]
8. [Extensively drug-resistant tuberculosis].
Lange C; Grobusch MP; Wagner D
Dtsch Med Wochenschr; 2008 Feb; 133(8):374-6. PubMed ID: 18270922
[TBL] [Abstract][Full Text] [Related]
9. Identification of the biosynthetic gene cluster and an additional gene for resistance to the antituberculosis drug capreomycin.
Felnagle EA; Rondon MR; Berti AD; Crosby HA; Thomas MG
Appl Environ Microbiol; 2007 Jul; 73(13):4162-70. PubMed ID: 17496129
[TBL] [Abstract][Full Text] [Related]
10. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM, and TUM. II. The susceptibility of antibiotic-resistant strains which were obtained in vitro to the five antibiotics (author's transl)].
Saito T; Fukuhara Y
Kekkaku; 1974 Apr; 49(4):91-6. PubMed ID: 4137393
[No Abstract] [Full Text] [Related]
11. Impact of bedaquiline and capreomycin on the gene expression patterns of multidrug-resistant Mycobacterium tuberculosis H37Rv strain and understanding the molecular mechanism of antibiotic resistance.
Miryala SK; Anbarasu A; Ramaiah S
J Cell Biochem; 2019 Sep; 120(9):14499-14509. PubMed ID: 30989745
[TBL] [Abstract][Full Text] [Related]
12. [Drug sensitivity in Mycobacterium tuberculosis versus its viability, cytotoxicity, genotype, and the course of the process in patients with pulmonary tuberculosis].
Manicheva OA; Lasunskaia EB; Zhuravlev VIu; Otten TF; Barnaulov AO; Mokrousov IV; Pavlova MV; Vishnevskiĭ BI; Narvskaia OV
Probl Tuberk Bolezn Legk; 2008; (12):18-22. PubMed ID: 19230183
[TBL] [Abstract][Full Text] [Related]
13. Discovery of new antitubercular oxazolyl thiosemicarbazones.
Sriram D; Yogeeswari P; Thirumurugan R; Pavana RK
J Med Chem; 2006 Jun; 49(12):3448-50. PubMed ID: 16759086
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic resistance mechanisms in M. tuberculosis: an update.
Nguyen L
Arch Toxicol; 2016 Jul; 90(7):1585-604. PubMed ID: 27161440
[TBL] [Abstract][Full Text] [Related]
15. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
16. [Drug resistance of Mycobacterium tuberculosis is the topical problem of phthisiology].
Samoĭlova AG; Mar'iandyshev AO
Probl Tuberk Bolezn Legk; 2005; (7):3-9. PubMed ID: 16130417
[No Abstract] [Full Text] [Related]
17. Purification and characterization of anthranilate synthase component I (TrpE) from Mycobacterium tuberculosis H37Rv.
Lin X; Xu S; Yang Y; Wu J; Wang H; Shen H; Wang H
Protein Expr Purif; 2009 Mar; 64(1):8-15. PubMed ID: 18952181
[TBL] [Abstract][Full Text] [Related]
18. [Critical concentrations for resistances of tubercle bacilli to tuberactinomycin-N, viomycin, capreomycin, and lividomycin in patients treated with these agents (cross-resistance-relationships among resistances to aminoglucoside-antibiotics found during chemotherapy for tuberculosis) (author's transl)].
Tsukamura M; Mizuno S; Murata H; Oshima T
Kekkaku; 1975 May; 50(4-5):123-30. PubMed ID: 49449
[No Abstract] [Full Text] [Related]
19. [Cross-resistance of tubercle bacilli (a review) (III) (author's transl)].
Tsukamura M
Kekkaku; 1977 Apr; 52(4):171-5. PubMed ID: 69737
[No Abstract] [Full Text] [Related]
20. Capreomycin resistance prediction in two species of Mycobacterium using a stacked ensemble method.
Chowdhury AS; Khaledian E; Broschat SL
J Appl Microbiol; 2019 Dec; 127(6):1656-1664. PubMed ID: 31419358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
